Alexion Pharmaceuticals, Inc. (ALXN)

[surf1944]

Alexion Pharmaceuticals, Inc. (ALXN): While the number of hedge funds invested in ALXN decreased from 21 at the end of the second quarter to 20 at the end of the third quarter, the total volume of hedge fund investment in the company increased dramatically, from $187.54 million at the end of June to $243.99 million at the end of September. Andreas Halvorsen’s Viking Global initiated a new position in ALXN worth $45.59 million in the third quarter. Louis Bacon’s Moore Global Investments also opened a new position in the company during the third quarter.

http://seekingalpha.com/article/317599-6-drug-companies-favored-by-hedge-funds?source=yahoo